Bellicum Pharma (BLCM) Reports Q4 Loss of $0.63/Share
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Join SI Premium – FREE
Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.63), versus ($0.66) reported last year.
For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
